Beata Casanas, DO FACP

Dr. Beata Casanas is an Associate Professor in the Division of Infectious Disease and International Medicine at the University of South Florida Morsani College of Medicine.  She is currently the Executive Medical Director of the Hillsborough County Health Department and responsible for developing clinical protocols, policies / procedures and supervision of the tuberculosis, HIV and STD clinics.  One of her interests is new advances in prevention and treatment of tuberculosis.  Dr. Casanas serves as attending for fellows, residents and medical students and is actively engaged in clinical teaching of infectious diseases at various levels within the University of South Florida academic programs at Tampa General Hospital.

Casanas is an accomplished polyglot and her professional interest in health disparities have been parlayed in various international and administrative academic concerns over the past few years. She has participated in various projects in India including the development of transplant tissue banking, and as a part of the faculty group of annual Indian HIV conferences sponsored by the University of South Florida CHART-India program.

She has established liaisons between the University of South Florida and the Department of Infectious Diseases in Poznan, Poland. Dr. Casanas in addition served as an American International Health Alliance faculty operative in the Central Asian Republics in connection with Infectious Diseases curriculum development and medical faculty improvement. She recently traveled with University of South Florida medical students and students from the College of Public Health to deliver free medical care for underserved populations in La Sabana, Dominican Republic.

Dr. Casanas has authored several articles for medical publications and is currently the Principal Investigator and Co-investigator for numerous research projects involving HIV and sexually transmitted diseases.

Areas of Expertise

Current Research

Principal Investigator

Gilead (GS-US-264-0106)                     Role: PI                           1/2011 – present
Phase 3 Randomized, Open-Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors to Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF) Fixed-dose Regimen in Virologically-Suppressed, HIV-1 Infected Patients

Ongoing Studies: Co-Investigator

Pfizer (A4001095)                                 Role: Co-Investigator      9/2011 – present
A Bulticenter, Randomized, Double Blind, Comparative Trial of Maraviroc + Duranavir/Ritonavir versus Emtricitabine/Tenofovir + Darunavir/Ritonavir for the Treatment of Antiretroviral-Naive HIV Infected Patients with CCR5 Tropic HIV-1

AMC PROTOCOL #072                         Role: Co-Investigator      8/2011 – present
National Institute of Child Health and Human Development (NICHD) NICHD Cooperative Agreement Number 2 U01 HD040474-11 Adolescent Medicine Trials Network for HIV-AIDS Interventions 2 U01 HD040474-11 Merck & Co., Inc National Cancer Institute: Protective Effect of Quadrivalent Vaccine in Young HIV-positive Males Who Have Sex with Males 

Pfizer (A4001098)                                Role: Co-Investigator      4/2011 – present
A Multicenter, Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety of Maraviroc in Combination with Other Antiretroviral Agents in HIV-1-Infected Subjects Co-Infected with Hepatitis C and/or Hepatitis B Virus

NICHD and NIAID (IMPAACT 1077HS) Role: Co-Investigator      1/2011 – present
HAART Standard Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere)  

Gilead Sciences (GS-US-236-0102):   Role: Co-Investigator     04/2010 – present
Phase III, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GW-9350 versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV 1 Infected, Antiretroviral Treatment-Naive Adults 

Gilead Sciences (GS-US-236-0103):   Role: Co-Investigator     04/2010 – present
Phase III, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GW-9350 versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV1 Infected Antiretroviral Treatment-Naive Adults

Gilead Sciences (GS-US-216-0114):    Role: Co-Investigator     04/2010 – present
Phase III, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of GS-9350-boosed Atazanavir versus Ritonavir-bosted Atazanavir Each Administered with Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

NIH (START):                                         Role: Co-Investigator       5/2009 – present
Strategic Timing of AntiRetroviral Treatment

Gilead (GS-US-183-0130)                     Role: Co-Investigator       5/2007 - present
Phase 3, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Comvination with other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects.

Publications

Ramarao S, Greene JN, Casanas BC, Carrington ML. Cutaneous Manifestations of Tuberculosis.  Infectious Diseases in Clinical Practice, submitted, 2012

Casanas BC, Pathak A, Tucci VT, Payor A, Vincent AL, Greene JN, Sandin RL. Non-gastrointestinal Aeromonas Hydrophila Infections in Cancer Patients. Infectious Diseases in Clinical Practice, accepted, 2011

Manry M, Cox J, Casanas BC, Quilitz RE, Greene JN.  Rituximab-Associated Occurence of Disseminated Miliary Tuberculosis.  Infectious Diseases in Clinical Practice 2012; 20(1): 82-84

Bhardwaj B, Naik E, Casanas BC, Breglia M, Lauzardo M. Tuberculosis Screening and Treatment of Latent Tuberculosis Infection among International College Students. Florida Public Health Review 2010; 7:26-31

Velez M, Casanas BC, Greene JN.  Pasteurella multocida Infections in Cancer Patients. Asian Biomedicine 2010; 4(3):449-455

Gompf SG, Casanas BC, Carrington M, Cunha BA. Herpangina. eMedicine from WebMD. Updated January 05, 2010. Available online.

Datta I, Casanas BC, Vincent AL, Greene JN. The Red Face: Erysipelas versus    Parvovirus B19, SLE and Rosacea. Asian Biomedicine 2009; 3(6)

Ghiya R, Naik E, Casanas B, Izurieta R, Marfatia Y. Clinico-Epidemiological Profile of HIV/TB Coinfected Patients in Vadodara, Gujarat. Indian Journal of Sexually Transmitted Diseases 2009; 30:10-5

Naik E, Casanas B, Pazare A,Wable G, Sinnott J, Salihu H. Cost of Treatment: The Single Biggest Obstacle To HIV/AIDS Treatment Adherence in Lower Middle Class Mumbai, India. Indian Journal of Sexually Transmitted Diseases 2009; 30:23-7

Casanas BC, Pothiawala S, Sinnott JT. An Elderly Man with NOMA Orofacial Gangrene. Infectious Diseases in Clinical Practice May 2009; 17(3):208-209

Casanas BC, Maldonado A, Diaz J, Logan J. Mycobacterium leprosum. Infections in Medicine 2008; 25(11): 526-527

Gompf ST, Casanas BC. Herpangina. eMedicine Journal [serial online]. 2008. Available online.  

Sinnott JT, Casanas B, Cooks A, Cooper C, et al. Abdominal Infections. In: MacCue J, Kahan S eds. In A Page Infectious Disease. Baltimore: Lippincott Williams & Wilkins, 2007.

Casanas BC. Tuberculosis – Are You at Risk? April 26, 2007. Available online. 

Casanas BC. Tuberculosis - What You Need to Know. May 30, 2007. Available online.

Gompf S, Herman BC, Tash K. Pseudomonas aeruginosa corneal ulcer. Clin Micro News Apr 2005; 27(8): 15:64-65

Gompf SG, Herman BC, Tash K, Sinnott JT. A Dim View: Corneal Ulcer after Remote Refractive Surgery, Infections in Medicine 2005; 22:621

Abstracts

Rosas L, Casanas B, Pathak A, Tucci V, Payor A, Vincent A, Greene J. Non-Gastrointestinal Aeromonas Hydrophila Infections in Cancer Patients. 49th Annual Meeting Infectious Disease Society of America, Boston, 2011

Casanas B, Oxner A, Lakshmi S, Georgiev H, D'Souza K, Mundra L, Sistrunk R, Pytlarz J, Wooley J, Sinnott JT. A University-Corporate Partnership to Enhance Vaccination Rates Among the Elderly: An Example of a Corporate Public Health Care Delivery. "Options for the Control of Influenza VII", Hong Kong, China - presented, November, 2010

Velez M, Casanas B, Greene J, Sandin R. Pasteurella multocida Infections in Cancer Patients. 47th Annual Meeting Infectious Disease Society of America, Philadelphia, 2009.

Frank R, Casanas B. Meningitis and fungemia caused by amphotericin B resistant Cryptococcus neoformans, Focus on Fungal Infections, Sanibel Harbour, 2009.

Casanas B, Benemon C, Lewis J, Olwe B, Russ D, Samuel-Wyatte D, Zamore B. These are the factors of our TB. Hillsborough County Health Department. Bureau of TB & Refugee Health Statewide Meeting: As The World Turns With TB And Refugee Health, Orlando, 2008.

Casanas BC, Wallach P, DeBaldo A, Conaboy K, Bognar B, Charles P, Orriola J, Nugmanova Z, Yegeubaeva S, Fedullo E. Developing faculty curriculum skills while addressing population health needs, AMEE, 2006.

Gompf S, Herman BC, Tash K, Grafals M. Corneal ulcer: A glimpse of complexity, American College of Physicians, Jacksonville, 2004.

Search Google Scholar for Publications by Beata Casanas, DO

Dr. Casanas BioSketch

Dr. Casanas' CV